Sean Kearney
Seasoned digital health and telemedicine investor-operator; prior exits include Lemonaid Health (acq. 23andMe), Invitae (NYSE: NVTA), RespondWell (acq. Zimmer Biomet), and CHS Therapy (acq. Strategic). Track record of scaling AI-driven healthtech companies and delivering exits for investors.
